Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (487)	1/22/2000 9:05:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 673

Torben: I was a consultant for the company, Univax Biologics, that initiated most of the vaccine development at NABI. Univax was merged with, at that time, North American Biologicals, a few years ago. I therefore feel that I shouldn't comment. My focus for the consulting was the vaccines for Gram-negative bugs. The list is derived from updates that I receive my email from "Closing Bell". I just cut and paste from stocks that I follow on a daily basis. Omission or inclusion doesn't have any meaning, other than perhaps that I'm a space case and don't update the list of stocks frequently enough. Cheers! Rick